Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in ILMN — Illumina, Inc.

CIK 886982 NEW YORK, NY
Back to ILMN Full portfolio

Position in ILMN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$93,071,036
+$39,298,323 QoQ
Shares Held
755,079
+84.2% QoQ
Ownership
0.499%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 95.9131428631971.ToString("F0")% Shared 0.ToString("F0")% None 4.086857136802904.ToString("F0")%

Common Shares in ILMN Over Time

Shares Held

Position Value (USD)

Derivatives in ILMN

reported options exposure · as of Jun 30, 2024
CallValue
$814,164
CallShares
7,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $5,861,764,434 across 35 Diagnostics & Research names. ILMN ranks #12 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 3,157,226 $1,551,871,293
2 DHR
Danaher Corp /De/
 4,609,288 $873,921,002
3 MTD
Mettler Toledo International Inc/
 387,844 $489,148,850
4 GH
Guardant Health, Inc.
 4,435,839 $409,738,446
5 A
Agilent Technologies, Inc.
 3,577,648 $407,780,316
6 IDXX
Idexx Laboratories Inc /De
 716,921 $402,830,739
7 DGX
Quest Diagnostics Inc
 1,348,694 $264,317,047
8 IQV
Iqvia Holdings Inc.
 1,177,280 $200,773,329

All Filings in ILMN

Export CSV
43 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $93,071,036 755,079
2025-12-31 $53,772,713 409,978
2025-09-30 $47,627,834 501,504
2025-06-30 $43,832,878 459,416
2025-03-31 $20,820,481 262,421
2024-12-31 $94,619,926 708,074
2024-09-30 $103,800,751 795,957
2024-06-30 $814,164 7,800
2024-06-30 $138,274,794 1,324,725
2024-03-31 $110,783,203 829,341
2023-12-31 $15,915,081 117,500
2023-12-31 $112,355,596 829,514
2023-09-30 $19,817,469 148,400
2023-09-30 $226,308,690 1,694,677
2023-06-30 $150,064,431 822,797
2023-03-31 $158,827,610 702,106
2022-12-31 $142,301,390 723,471
2022-09-30 $161,358,240 869,418
2022-06-30 $126,591,638 705,881
2022-03-31 $6,287,841 18,500
2022-03-31 $280,247,714 824,541
2021-12-31 $4,107,863 11,100
2021-12-31 $244,861,234 661,648
2021-09-30 $301,743,490 764,755
2021-09-30 $3,353,779 8,500
2021-06-30 $4,787,338 10,400
2021-06-30 $4,649,242 10,100
2021-06-30 $336,733,555 731,519
2021-03-31 $2,465,754 6,600
2021-03-31 $4,296,390 11,500
2021-03-31 $222,232,119 594,841
2020-12-31 $5,866,731 16,300
2020-12-31 $202,585,806 562,860
2020-12-31 $5,686,770 15,800
2020-09-30 $262,521,083 873,145
2020-09-30 $1,202,646 4,000
2020-09-30 $6,614,553 22,000
2020-06-30 $525,090,661 1,457,522
2020-06-30 $7,385,383 20,500
2020-06-30 $2,089,523 5,800
2020-03-31 $2,895,921 10,900
2020-03-31 $1,912,902 7,200
2020-03-31 $404,810,544 1,523,672

Report a Problem

Category
Description
Email (optional, for follow-up)